表紙
市場調査レポート

中国のクエチアピン市場の分析

Investigation Report on China Quetiapine Market, 2010-2019

発行 China Research and Intelligence 商品コード 296868
出版日 ページ情報 英文 30 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=101.75円で換算しております。
Back to Top
中国のクエチアピン市場の分析 Investigation Report on China Quetiapine Market, 2010-2019
出版日: 2015年07月24日 ページ情報: 英文 30 Pages
概要

アストラゼネカ社が開発したクエチアピンは、統合失調症の重要な治療薬です。クエチアピンは、中国市場に参入以降、急成長を示しています。年間売上高は、2014年に1億3,100万人民元に達し、2010年〜2014年のCAGRで9.72%の成長を遂げました。

当レポートでは、中国のクエチアピン市場について調査分析し、市場規模、市場シェア、小売価格、主要メーカー、市場見通しなどについて、体系的な情報を提供しています。

第1章 クエチアピンの関連概念

  • 適応
  • 世界市場の販売状況

第2章 中国のクエチアピンの市場プロファイル

  • 特許状況と承認情報
  • 主要メーカー
  • 市場規模

第3章 中国のクエチアピンの販売状況の分析

  • 売上高
  • 売上数量

第4章 中国のクエチアピン主要メーカーの市場シェア分析

  • 市場シェア:売上高別
  • 市場シェア:売上数量別

第5章 中国のクエチアピンの剤形別の分析

  • 市場シェア (剤形別) :売上高別
  • 市場シェア (剤形別) :売上数量別

第6章 中国のクエチアピンの病院向け基準価格

  • Hunan Dongting Pharmaceutical Co., Ltd.
  • Suzhou Pharmaceutical Group Co., Ltd.
  • アストラゼネカ

第7章 中国のクエチアピン市場の主要メーカー

  • Hunan Dongting Pharmaceutical Co., Ltd.
  • Suzhou Pharmaceutical Group Co., Ltd.
  • アストラゼネカ

第8章 中国のクエチアピンの市場見通し

  • 市場規模の予測
  • 競合情勢の予測

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: 1507274

WHO estimated that the lifetime prevalence of schizophrenia is about 3.8%-8.4% in the world. According to the statistics published by National Center for Mental Health in 2014, the number of people with mental disorders is above 100 million. Suppose the mainland population was 1368 million, the number of people with schizophrenia shall be about 17.8 million. Symptoms of schizophrenia begin earlier in men than in women and are more common to see in men than in women. The risk of dying young in schizophrenia patients is 2 to 2.5 times that in common people. This is the result of increased physical health problems like cardiovascular, metabolic and epidemic diseases. Take diabetes for example, its incidence among schizophrenia patients is 2-3 times that in common people.

Developed by AstraZeneca plc., quetiapine (under the trade name of Seroquel) is an important drug for the treatment of schizophrenia. Approved by CFDA to treat schizophrenia in 2000, quetiapine was listed in the Catalogue of Drugs for the Basic National Medical Insurance in 2014. Currently, local manufacturers of quetiapine are Hunan Dongting Pharmaceutical Co., Ltd and Suzhou Pharmaceutical Group Co., Ltd. No.1 Pharmaceutical Factory, the former owning relevant patent for quetiapine compound according to CFDA.

Quetiapine develops fast after entering China, sales value reaching CNY 116 million in 2013 and CNY 131 million in 2014 with a year-on-year growth of 12.93% and CAGR reaching 9.72% during the period of 2010-2014. With accelerating pace of life and increased life pressure, the incidence of mental disorder keeps going up, which fosters the vast demand for quetiapine in China. Currenly, Hunan Dongting Pharmaceutical Co., Ltd, Suzhou Pharmaceutical Group Co., Ltd. No.1 Pharmaceutical Factory and AstraZeneca plc. Occupy the majority of market share, among which AstraZeneca plc. Had the largest share of 78.50% for sales value in 2014. As local enterprises have patented quetiapine compound and sold it at a relatively low price, their market share is expected to expand in the next few years.

Readers can get at least the following information from this report:

  • market size of quetiapine in China
  • retail price of quetiapine in China
  • market outlook of quetiapine in China

The author suggests the following groups of people purchase this report:

  • manufacturers of antipsychotics
  • investors/ research institutions interested in Chinese medicine market
  • any interest in the medicine market, please contact CRI for customized survey service

Table of Contents

1. Related Concepts of Quetiapine

  • 1.1. Indication
  • 1.2. Sales Status in Global Market

2. Market Profile of Quetiapine in China

  • 2.1. Patent Status and Approval Information of Quetiapine in China
  • 2.2. Major Manufacturers
  • 2.3. Market Size

3. Survey on Sales Status of Quetiapine in China, 2010-2014

  • 3.1. Sales Value
    • 3.1.1. Overall Sales Value
    • 3.1.2. Sales Value by Regions
  • 3.2. Sales Volume
    • 3.2.1. Overall Sales Volume
    • 3.2.2. Sales Volume by Regions

4. Survey on Market Share of Major Manufacturers of Quetiapine in China, 2010-2014

  • 4.1. Market Share by Sales Value
  • 4.2. Market Share by Sales Volume

5. Survey on Dosage Forms of Quetiapine in China, 2010-2014

  • 5.1. Share of Different Dosage Forms by Sales Value
  • 5.2. Share of Different Dosage Forms by Sales Volume

6. Reference Price of Quetiapine in Chinese Hospitals in 2014

  • 6.1. Hunan Dongting Pharmaceutical Co., Ltd (Trade Name: Qiwei)
  • 6.2. Suzhou Pharmaceutical Group Co., Ltd. No.1 Pharmaceutical Factory (Trade Name: Shuling)
  • 6.3. AstraZeneca plc. (Trade Name: Seroquel)

7. Major Manufacturers of Quetiapine in Chinese Market, 2010-2014

  • 7.1. Hunan Dongting Pharmaceutical Co., Ltd
  • 7.2. Suzhou Pharmaceutical Group Co., Ltd. No.1 Pharmaceutical Factory
  • 7.3. AstraZeneca plc.

8. Market Outlook of Quetiapine in China, 2015-2019

  • 8.1. Forecast of Market Size
  • 8.2. Forecast of Competitive Landscape

Table of Selected Charts

  • Chart Patent Status of Quetiapine in China
  • Chart Approval Information of Quetiapine in China
  • Chart Sales Status of Quetiapine in China
  • Chart Sales Value of Quetiapine in China, 2010-2014
  • Chart Sales Value of Quetiapine in Some Regions in China, 2010-2014
  • Chart Sales Volume of Quetiapine in China, 2010-2014
  • Chart Sales Volume of Quetiapine in Some Regions in China, 2010-2014
  • Chart Market Share of TOP3 Manufacturers of Quetiapine by Sales Value in China, 2010-2014
  • Chart Sales Value and Market Share of Quetiapine Made by Hunan Dongting Pharmaceutical Co., Ltd in China, 2010-2014
  • Chart Sales Value and Market Share of Quetiapine Made by Suzhou Pharmaceutical Group Co., Ltd. No.1 Pharmaceutical Factory in China, 2010-2014
  • Chart Sales Value and Market Share of Quetiapine Made by AstraZeneca plc. in China, 2010-2014
  • Chart Price of Quetiapine Made by Hunan Dongting Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
  • Chart Price of Quetiapine Made by Suzhou Pharmaceutical Group Co., Ltd. No.1 Pharmaceutical Factory in Some Chinese Cities in 2014
  • Chart Price of Quetiapine Made by AstraZeneca plc. in Some Chinese Cities in 2014
Back to Top